Status:

COMPLETED

Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding

Lead Sponsor:

Far Eastern Memorial Hospital

Conditions:

Esophageal and Gastric Varices

Gastrointestinal Hemorrhage

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Prophylactic antibiotics have been routinely recommended for cirrhotic patients with upper gastrointestinal bleeding recently. However, the regimen and duration of its use remain an inconclusive issue...

Detailed Description

1. Patient including \& excluding Criteria Including: Those were diagnosed to have gastro-esophageal variceal bleeding after endoscopic examination. No evidence suggestive of infection was found inclu...

Eligibility Criteria

Inclusion

  • those patients suffering from variceal bleeding documented by endoscopic examination and without apparent evidence of infection.

Exclusion

  • received antibiotics within 2 weeks, less than 18 years old, get pregnant, have malignancy other than HCC, have allergy to ceftrioxone

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2013

Estimated Enrollment :

79 Patients enrolled

Trial Details

Trial ID

NCT00838864

Start Date

March 1 2009

End Date

April 1 2013

Last Update

August 31 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Far Eastern Memorial Hospital

Taipei, Taiwan, 22050